Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07654283 · ClinicalTrials.gov registry record · Phase 2
Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
A Phase 2 study, sponsored by AusperBio Therapeutics.
- Not yet
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT07654283: Clinical Trial Phase 2 study, sponsored by AusperBio Therapeutics.
NCT07654283 is a Phase 2 study that has not yet begun recruiting, run by AusperBio Therapeutics. The registered enrollment target is 70 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07654283, a Phase 2 study, has not yet begun recruiting, sponsored by AusperBio Therapeutics.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with CHB treated with Nucleos(t)ide Analogue (NAs).
Interventions
- DRUG AHB-137
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-06-17 |
| Est. Completion | 2028-07-26 |
| Phase | Phase 2 |
What is known before NCT07654283 opens enrollment
NCT07654283 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 1 intervention - of which AHB-137 is the first listed.
NCT07654283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07654283 about?
NCT07654283 is a clinical study titled "Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions". This study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with CHB treated with Nucleos(t)ide Analogue (NAs).
What is the current status of trial NCT07654283?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2026-06-17. Estimated completion is 2028-07-26.
What interventions are being tested in trial NCT07654283?
The interventions under investigation include: AHB-137 (DRUG).
Who is sponsoring clinical trial NCT07654283?
This trial is sponsored by AusperBio Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07654283's enrollment target sits among peer trials
70 937th of 2000 higher than 1,036 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI